Skip to main content
Top
Published in: European Radiology 7/2015

01-07-2015 | Oncology

Optimal follow-up intervals in active surveillance of renal masses in patients with von Hippel-Lindau disease

Authors: Fabio Pomerri, Giuseppe Opocher, Chiara Dal Bosco, Pier Carlo Muzzio, Gisella Gennaro

Published in: European Radiology | Issue 7/2015

Login to get access

Abstract

Objectives

To estimate an optimal follow-up (FU) interval for von Hippel-Lindau (VHL) patients with renal masses (RMs) by determining tumour growth rates from growth curves.

Methods

Thirty lesions (47.6 %) were classified as solid tumours (STs) and 33 (52.4 %) as complex cysts (CCs). Variations in lesion volume over time were analyzed. For 53 lesions, we calculated the growth rate during the period when the volume of the lesion changed most rapidly, and called this the fast growth rate (FGR).

Results

The STs initially grew fast, followed by a period of slower growth. The CCs varied in volume over time, associated with variable amounts of their fluid component. The FGR correlated better with the latest volume for STs (r = 0.905) than for CCs (r = 0.780). An optimal FU interval between 3 and 12 months was derived by combining the FGR calculated from the curve with the latest volume measured.

Conclusions

Analyzing growth curves and related kinetic parameters for RMs in VHL patients could be useful with a view to optimizing the subsequent FU interval and improving the active surveillance program.

Key Points

Measuring volume changes over time enables tumour growth curves to be charted.
Renal solid tumours increase in volume with a typical sigmoidal curve.
Complex cysts may increase and decrease in volume spontaneously over time.
The fast growth rate of solid tumours correlates with their latest volume.
The fast growth rate can orient the scheduling of subsequent follow-ups.
Literature
1.
2.
go back to reference Verine J, Pluvinage A, Bousquet G et al (2010) Hereditary renal cancer syndromes: An update of a systematic review. Eur Urol 58:701–710PubMedCrossRef Verine J, Pluvinage A, Bousquet G et al (2010) Hereditary renal cancer syndromes: An update of a systematic review. Eur Urol 58:701–710PubMedCrossRef
3.
go back to reference Kim JJ, Rini BI, Hansel DE (2010) Von hippel lindau syndrome. Adv Exp Med Biol 685:228–249PubMed Kim JJ, Rini BI, Hansel DE (2010) Von hippel lindau syndrome. Adv Exp Med Biol 685:228–249PubMed
4.
go back to reference Latif F, Tory K, Gnarra J et al (1993) Identification of the von hippel-lindau disease tumor suppressor gene. Science 260:1317–1320PubMedCrossRef Latif F, Tory K, Gnarra J et al (1993) Identification of the von hippel-lindau disease tumor suppressor gene. Science 260:1317–1320PubMedCrossRef
5.
go back to reference Meister M, Choyke P, Anderson C, Patel U (2009) Radiological evaluation, management, and surveillance of renal masses in von hippel-lindau disease. Clin Radiol 64:589–600PubMedCrossRef Meister M, Choyke P, Anderson C, Patel U (2009) Radiological evaluation, management, and surveillance of renal masses in von hippel-lindau disease. Clin Radiol 64:589–600PubMedCrossRef
6.
go back to reference Choyke PL, Glenn GM, Walther MM et al (1992) The natural history of renal lesions in von hippel-lindau disease: A serial CT study in 28 patients. AJR Am J Roentgenol 159:1229–1234PubMedCrossRef Choyke PL, Glenn GM, Walther MM et al (1992) The natural history of renal lesions in von hippel-lindau disease: A serial CT study in 28 patients. AJR Am J Roentgenol 159:1229–1234PubMedCrossRef
7.
go back to reference Walther MM, Choyke PL, Glenn G et al (1999) Renal cancer in families with hereditary renal cancer: Prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161:1475–1479PubMedCrossRef Walther MM, Choyke PL, Glenn G et al (1999) Renal cancer in families with hereditary renal cancer: Prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161:1475–1479PubMedCrossRef
8.
go back to reference Duffey BG, Choyke PL, Glenn G et al (2004) The relationship between renal tumor size and metastases in patients with von hippel-lindau disease. J Urol 172:63–65PubMedCrossRef Duffey BG, Choyke PL, Glenn G et al (2004) The relationship between renal tumor size and metastases in patients with von hippel-lindau disease. J Urol 172:63–65PubMedCrossRef
9.
go back to reference Ploussard G, Droupy S, Ferlicot S et al (2007) Local recurrence after nephron-sparing surgery in von hippel-lindau disease. Urology 70:435–439PubMedCrossRef Ploussard G, Droupy S, Ferlicot S et al (2007) Local recurrence after nephron-sparing surgery in von hippel-lindau disease. Urology 70:435–439PubMedCrossRef
10.
go back to reference Boss A, Clasen S, Kuczyk M, Schick F, Pereira PL (2007) Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol 17:725–733PubMedCrossRef Boss A, Clasen S, Kuczyk M, Schick F, Pereira PL (2007) Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol 17:725–733PubMedCrossRef
11.
go back to reference Shingleton WB, Sewell PE Jr (2002) Percutaneous renal cryoablation of renal tumors in patients with von hippel-lindau disease. J Urol 167:1268–1270PubMedCrossRef Shingleton WB, Sewell PE Jr (2002) Percutaneous renal cryoablation of renal tumors in patients with von hippel-lindau disease. J Urol 167:1268–1270PubMedCrossRef
12.
go back to reference Afenya EK, Calderon CP (2000) Diverse ideas on the growth kinetics of disseminated cancer cells. Bull Math Biol 62:527–542PubMedCrossRef Afenya EK, Calderon CP (2000) Diverse ideas on the growth kinetics of disseminated cancer cells. Bull Math Biol 62:527–542PubMedCrossRef
13.
go back to reference Bajzer Z (1999) Gompertzian growth as a self-similar and allometric process. Growth Dev Aging 63:3–11PubMed Bajzer Z (1999) Gompertzian growth as a self-similar and allometric process. Growth Dev Aging 63:3–11PubMed
14.
go back to reference Domingues JS (2012) Gompertz model: Resolution and analysis for tumors. J Math Model Appl 1:70–77 Domingues JS (2012) Gompertz model: Resolution and analysis for tumors. J Math Model Appl 1:70–77
15.
go back to reference Collins VP, Loeffler RK, Tivey H (1956) Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 76:988PubMed Collins VP, Loeffler RK, Tivey H (1956) Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 76:988PubMed
16.
go back to reference Jilg CA, Neumann HP, Glasker S et al (2012) Growth kinetics in von hippel-lindau-associated renal cell carcinoma. Urol Int 88:71–78PubMedCrossRef Jilg CA, Neumann HP, Glasker S et al (2012) Growth kinetics in von hippel-lindau-associated renal cell carcinoma. Urol Int 88:71–78PubMedCrossRef
17.
go back to reference Zhang J, Pan JH, Dong BJ, Xue W, Liu DM, Huang YR (2012) Active surveillance of renal masses in von hippel-lindau disease: Growth rates and clinical outcome over a median follow-up period of 56 months. Fam Cancer 11:209–214PubMedCrossRef Zhang J, Pan JH, Dong BJ, Xue W, Liu DM, Huang YR (2012) Active surveillance of renal masses in von hippel-lindau disease: Growth rates and clinical outcome over a median follow-up period of 56 months. Fam Cancer 11:209–214PubMedCrossRef
18.
go back to reference Bosniak MA (1997) The use of the bosniak classification system for renal cysts and cystic tumors. J Urol 157:1852–1853PubMedCrossRef Bosniak MA (1997) The use of the bosniak classification system for renal cysts and cystic tumors. J Urol 157:1852–1853PubMedCrossRef
20.
go back to reference Pedrosa I, Chou MT, Ngo L et al (2008) MR classification of renal masses with pathologic correlation. Eur Radiol 18:365–375PubMedCrossRef Pedrosa I, Chou MT, Ngo L et al (2008) MR classification of renal masses with pathologic correlation. Eur Radiol 18:365–375PubMedCrossRef
21.
22.
go back to reference Choi SJ, Kim HS, Ahn SJ, Park Y, Choi HY (2012) Differentiating radiological features of rapid- and slow-growing renal cell carcinoma using multidetector computed tomography. J Comput Assist Tomogr 36:313–318PubMedCrossRef Choi SJ, Kim HS, Ahn SJ, Park Y, Choi HY (2012) Differentiating radiological features of rapid- and slow-growing renal cell carcinoma using multidetector computed tomography. J Comput Assist Tomogr 36:313–318PubMedCrossRef
23.
go back to reference Kurup AN, Thompson RH, Leibovich BC et al (2012) Renal oncocytoma growth rates before intervention. BJU Int 110:1444–1448PubMedCrossRef Kurup AN, Thompson RH, Leibovich BC et al (2012) Renal oncocytoma growth rates before intervention. BJU Int 110:1444–1448PubMedCrossRef
24.
go back to reference Li XS, Yao L, Gong K et al (2012) Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention. J Cancer Res Clin Oncol 138:269–274PubMedCrossRef Li XS, Yao L, Gong K et al (2012) Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention. J Cancer Res Clin Oncol 138:269–274PubMedCrossRef
25.
go back to reference Kassouf W, Aprikian AG, Laplante M, Tanguay S (2004) Natural history of renal masses followed expectantly. J Urol 171:111–113PubMedCrossRef Kassouf W, Aprikian AG, Laplante M, Tanguay S (2004) Natural history of renal masses followed expectantly. J Urol 171:111–113PubMedCrossRef
26.
go back to reference Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745PubMedCrossRef Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745PubMedCrossRef
27.
go back to reference Lamb GW, Bromwich EJ, Vasey P, Aitchison M (2004) Management of renal masses in patients medically unsuitable for nephrectomy–natural history, complications, and outcome. Urology 64:909–913PubMedCrossRef Lamb GW, Bromwich EJ, Vasey P, Aitchison M (2004) Management of renal masses in patients medically unsuitable for nephrectomy–natural history, complications, and outcome. Urology 64:909–913PubMedCrossRef
28.
go back to reference Lee JY, Kim CK, Choi D, Park BK (2008) Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: A single-institution experience. Eur Radiol 18:731–737PubMedCrossRef Lee JY, Kim CK, Choi D, Park BK (2008) Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: A single-institution experience. Eur Radiol 18:731–737PubMedCrossRef
Metadata
Title
Optimal follow-up intervals in active surveillance of renal masses in patients with von Hippel-Lindau disease
Authors
Fabio Pomerri
Giuseppe Opocher
Chiara Dal Bosco
Pier Carlo Muzzio
Gisella Gennaro
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 7/2015
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-3591-9

Other articles of this Issue 7/2015

European Radiology 7/2015 Go to the issue